Yungjin to launch generic Actos

Published: 2008-07-21 06:55:00
Updated: 2008-07-21 06:55:00
Yungjin Pharm says it will launch the first generic version of Actos (pioglitazone hydrochloride), Glitzone 15 mg (823 won per tablet) from August 1.

Actos is a medication that is commonly prescribed to treat type 2 diabetes in adults. It is a form of thiazolidinedione, which works to lower an...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.